Drug Information

Drug General Information
Drug ID
D0AH6V
Former ID
DIB007452
Drug Name
BN-2629
Synonyms
SG-2000; SJG-136; SP-2001
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1/2 [524598]
Company
Spirogen Ltd
Structure
Download
2D MOL

3D MOL
Canonical SMILES
C1(=O)N2[C@H](C=Nc3c1cc(c(c3)OCCCOc1cc3c(C(=O)N4[C@H](C<br />=N3)CC(=C)C4)cc1OC)OC)CC(=C)C2
CAS Number
CAS 232931-57-6
Target and Pathway
Target(s) Human DNA Target Info Binder [544065]
References
Ref 524598ClinicalTrials.gov (NCT02034227) Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia. U.S. National Institutes of Health.
Ref 544065Single-Nucleotide Polymorphisms in Rv2629 Are Specific for Mycobacterium tuberculosis Genotypes Beijing and Ghana but Not Associated with Rifampin Resistance . J Clin Microbiol. 2009 January; 47(1): 223-226.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.